Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Guangzhou Baiyunshan Pharmaceutical Holdings (874 HK)
Watchlist
91
Analysis
Health Care
•
China
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. manufactures and sells Chinese patent medicine. The Company also wholesales, retails, imports, and exports Western and Chinese pharmaceutical products and various medical apparatus.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
24 Oct 2020 19:08
Quiddity Weekly H/A: Share Spread Monitor 23 Oct 2020
Quiddity H/A Spread Monitor for the week ending 23 October 2020. Spreads widened in Consumer, narrowed in every other sector. Southbound were...
Travis Lundy
Follow
816 Views
Share
bullish
•
Hutchison China MediTech Ltd
•
25 Apr 2019 15:23
Hutchison-China Meditech (和黄医药) H-Share Listing: MNC Partnerships Endorsed Its R&D Capabilities
Hutchison-China Meditech, China-based AIM and NASDAQ dual listed pharmaceutical company, is seeking to raise up to USD 500 million via a Hong Kong...
Ke Yan, CFA, FRM
Follow
654 Views
Share
bullish
•
M1 Ltd
•
06 Jan 2019 08:47
Last Week in Event SPACE: M1, Healius, Thanachart, Faroe, JCNC, Jardines
Last Week in Event SPACE ... On a Risk/Reward basis, the arb is not very attractive at M1 Ltd (M1 SP)'s current price. Pricing aside, Jangho...
David Blennerhassett
Follow
689 Views
Share
bullish
•
Yichang HEC Changjiang Pharma
•
02 Jan 2019 15:09
Discover HK Connect: Mainlanders Were Buying Pharma and Property Managers in December
In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...
Ke Yan, CFA, FRM
Follow
618 Views
Share
bullish
•
Shanghai Fosun Pharmaceutical (Group)
•
17 Dec 2018 11:06
Discover HK Connect: Mainlanders Are Buying Shandong Gold, and Pharmaceuticals (2018-12-17)
In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...
Ke Yan, CFA, FRM
Follow
438 Views
Share
First
Previous
6
7
8
9
10
11
12
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x